Hibiscus extract

Pharmacological properties

The patented hibiscus extract, which determines the pharmacological properties of the drug, is a source of organic acids (citric, hydroxy succinic, pyrocatechol, hibisc), vitamins, polysaccharides, bioflavonoids, which determine the bacteriostatic effect of the drug aflazin in relation to most urinary tract infections (staphylococococcus spp. , enterococcus faecalis, escherichia coli, enterobacter spp., candida spp., etc.). It has an anti-inflammatory, anti-edematous effect, exhibits anti-adhesive effect, which makes it impossible for adhesion (adhesion) of microorganisms to the walls of the urinary tract, their development and reproduction. prevents the development of dysuric phenomena.

Pharmacokinetics Not studied.

Indications

As part of complex therapy for acute and chronic infections of the bladder (cystitis) and kidneys (pyelonephritis), with asymptomatic bacteriuria, including in pregnant women. chronic non-infectious diseases of the kidneys (glomerulonephritis, interstitial nephritis), prevention of urinary tract infections, including after instrumental studies (endoscopic, radiological and gynecological studies).

Prevention of the formation of urinary calculi, including after their removal.

Application

Adults and children over the age of 12 use 1 capsule 2 times a day, regardless of food intake. children aged 6-12 years - 1 capsule 1 time per day. the duration of use is determined by the doctor individually, depending on the severity of the disease. the recommended duration of use in acute inflammation of the urinary tract and exacerbation of chronic diseases is 4-6 weeks. for preventive purposes, the course of use is 2–4 weeks.

Children. The drug is used in children over the age of 6 years.

Contraindications

Individual hypersensitivity to any of the components of the drug.

Side effects

Allergic reactions to the components of the drug are possible.

special instructions

Since the drug contains lactose, it should not be used in patients with rare hereditary forms of galactose intolerance, lactose deficiency or glucose-galactose malabsorption syndrome.

Use during pregnancy and lactation. The use of the drug in the first trimester of pregnancy is possible only as directed by a doctor. The use of the drug during pregnancy, starting from the second trimester, as well as during breastfeeding, does not require additional medical advice.

Influence on the ability to drive vehicles or other mechanisms. Does not affect.

Interactions

Clinically significant interaction of the drug with other drugs has not been established. aflazine can be used in combination with antibiotics and other antimicrobial agents.

Overdose

Cases of drug poisoning due to its overdose are unknown.

Storage conditions

In the original packaging at a temperature not exceeding 25 ° c.